To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
WebMD
Karmanos multiple myeloma survivor Robert Brooks and Craig Cole, M.D., join WebMD's Health Discovered podcast to talk about the following topics surrounding health equity in multiple myeloma care:
Dr. Cole is a hematologist at Karmanos Cancer Institute at McLaren Greater Lansing and a member of the Multiple Myeloma and Amyloidosis and Hematology Oncology Multidisciplinary Teams (MDTs) at Barbara Ann Karmanos Cancer Institute. Brooks explains why he chose Karmanos for his treatment and decided to participate in a clinical trial under the care of Jeffrey Zonder, M.D., hematologist and oncologist, leader of the Multiple Myeloma and Amyloidosis MDT and member of the Hematology Oncology MDT.
Your browser does not support the audio element.
Download Podcast